A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer

A.W. Tolcher, D.I. Quinn, A. Ferrari, F. Ahmann, G. Giaccone, T. Drake, A. Keating, J.S. de Bono

Research output: Contribution to journal › Article › Academic › peer-review

Access to Document

@article{673369e3bd86402aa16e0a33b0abdb11,

title = "A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer",

author = "A.W. Tolcher and D.I. Quinn and A. Ferrari and F. Ahmann and G. Giaccone and T. Drake and A. Keating and {de Bono}, J.S.",

year = "2012",

doi = "10.1093/annonc/mdr353",

language = "Undefined/Unknown",

volume = "23",

pages = "968--9U9",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer

AU - Tolcher, A.W.

AU - Quinn, D.I.

AU - Ferrari, A.

AU - Ahmann, F.

AU - Giaccone, G.

AU - Drake, T.

AU - Keating, A.

AU - de Bono, J.S.

PY - 2012

Y1 - 2012

U2 - 10.1093/annonc/mdr353

DO - 10.1093/annonc/mdr353

M3 - Article

C2 - 21859898

VL - 23

SP - 968-9U9

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 4

ER -